VEGFD and cancer: EGCG treatment reduced VEGF-D secretion in inflammatory breast cancer cells SUM-149 and SUM-190, resulting in reduction of lymphatic endothelial cell migration and tube formation, leading to inhibition of metastasis of cancer cells (120).